Lactic acid bacteria
a b s t r a c t
Lactic acid bacteria (LAB) symbionts of honeybees are certainly playing key roles in their host's colony functioning. The defense against bacterial pathogen invasion by endogenous LAB has been considered as promising and usable phenomenon. This study addresses bacteriocinogeny as one of antibacterial action mode displayed by bacteria. The honeybee endogenous LAB isolated from worker honeybee intestines (61 strains), queen honeybee intestines (16 strains) and beebread (25 strains) were tested for bacteriocin production ability. We checked also well characterized bacteriocin producing LAB strains against bacteria causing American foulbrood (AFB) e Paenibacillus larvae aiming possible use of exogenous LAB for control AFB in honeybees and in the same time to observe the vulnerability of endogenous bacteria exposed to bacteriocin producers. We demonstrated that none of 102 studied LAB strains, isolated from worker honeybee intestines, from queen honeybee intestines and from beebread, produced bacteriocins detectable by the well diffusion method (WDM). All of them failed to inhibit two strains of P. larvae.
Three exogenous bacteriocin-producing LAB strains were tested against the same pathogens and against 25 endogenous bacterial isolates representing 11 different LAB species. The screening showed that all the tested exogenous bacteriocin-producing strains inhibited the tested P. larvae strains. The endogenous LAB strains exhibited varied sensitivity profiles when treated with bacteriocin-producing strains. This raises similar challenges to those observed in antibiotic applications leading to dysbacteriosis, even though the efficacy of these bacteriocins against P. larvae in an in vitro system is evident. 
Introduction
Several multifaceted benefits of the symbiosis of insects and their microbiota have been proposed and intensively studied.
The composition of the gut bacterial communities of social insects has been shaped by coevolution. The social behavior of honeybees provides favorable conditions for the exchange of the symbiont microbes [1] and these microorganisms are efficiently transmitted between bee colony members and their different generations. The gut microbial composition of insects, and especially honeybees, is unique, harboring particular, niche-adapted bacterial species characterized by a high degree of genetic diversity within each of these species [2] .
However, not all the bacteria present in the gut might be favorable for the host insect [3] . A real understanding of the distinctions between symbiosis, commensalism and parasitism is limited by our knowledge about the exact functional roles of these microorganisms. At the same time, numerous attempts have been made to use microbial symbionts as a tool to solve insect health problems [4e6] .
An understanding of the symbiotic relationship between honeybees and their bacterial communities could inspire ideas of how to exploit this microflora for the protection of the host's health. The question of whether endogenous bacterial symbionts suppress honeybee pathogenic bacteria has been asked and analyzed many times. However, no direct or clear evidence supporting this hypothesis has ever been found. The use of exogenous LAB as an alternative active flora has also been proposed [7, 8] . Particular attention has been paid to testing exogenous LAB strains that produce bacteriocins.
The general term of Microbial Resource Management (MRM) [9] has been applied in the scientific literature describing insect microbiota [4] .
The definition of animal probiotics is based on the principle that probiotics are live microorganisms suppressing intestinal infections, increasing production, strengthening animal growth and defending the gastrointestinal environment against morbidity [10] . In the same review, endogenous symbiotic bacteria are described as contributing to host health by their action in digestion, gut wall function and cooperation with the gut immune system. Different authors share almost the same understanding of the honeybee bacterial symbiont function [5, 11] . Two major bacterial diseases of honeybees affect honeybee offspring, one of which, American foulbrood (AFB) caused by spore-forming Paenibacillus larvae, is listed as a severe disease presenting a considerable threat to beekeeping [12] .
Over the decades, AFB has been routinely treated with antibiotics, which has resulted in the emergence of antibioticresistant P. larvae strains and the transmission of antibiotic resistance genes between bacterial residents of the honeybee gut [13] .
Moreover, treatment of honeybees with antibiotics leads to commercial problems because of the persistence of the antibiotic residues in honey after their application in the apiaries [14] . These harmful consequences of antibiotic use are driving the search for alternatives for the treatment and prevention of honeybee infectious diseases.
The study aimed to reveal antimicrobial activities of honeybee's endogenous LAB and to explore antimicrobial potential of exogenous bacteriocin-producing LAB against bacteria causing American foulbrood e P. larvae and endogenous LAB.
Materials and methods

Assay of antimicrobial activities
All previously isolated honeybee endogenous LAB strains (102) [15] were tested for antimicrobial activity by the agar well diffusion method [16] . LAB strains were grown overnight in MRS broth supplemented with L-cysteine (0.1%) and fructose (2%) at pH 6.7. Cell-free supernatants (CFS) were obtained by centrifugation of overnight cultures at 8000 g for 10 min at 4 C. CFS was divided into two fractions, one of which was adjusted to pH 6.5 with NaOH 5 N.
As a positive control, three bacteriocin-producing strains, Enterococcus durans A5-11 [17] , Enterococcus faecalis KT2W2G [18] , and Lactococcus lactis subsp. lactis KT2W2L [19] , were propagated overnight in M17 broth and their CFS were prepared as described above.
In addition, an aliquot of CFS (pH adjusted to 7.0) was treated with the enzyme proteinase K at a final concentration of 1 mg/ml.
A bacteriocin-sensitive strain of Lactobacillus, L. sakei subsp. sakei JCM 1157, was used as the indicator bacteria (positive control) and two P. larvae strains, ATCC 9545 and 07/ 13 (CRA-API collection), were used for sensitivity tests with supernatants of all the LAB overnight cultures studied. (P. larvae strains were kindly provided by Emanuele Carpana e Consiglio per la Ricerca e la Sperimentazione in Agricoltura e Unit a di Ricerca per l'Apicoltura e la Bachicoltura). The Lactobacillus indicator strain was cultured in MRS broth at 37 C to the early stationary growth phase. Twenty microliters of this culture were then added to 20 ml of soft MRS agar (0.8% w/v), mixed and poured onto sterile Petri dishes.
P. larvae strains were cultured at 37 C for 48 h in BraineHeart Infusion (BHI) broth supplemented with thiamine hydrochloride 1 mg/L (adjusted to pH 6.6 with HCl). Four hundred microliters of P. larvae cultures were added to 20 ml of soft BHI agar (0.8% w/v), mixed and poured onto sterile Petri dishes.
In the lawn of hardened soft agars, wells (10 mm in diameter) were prepared and then aliquots (50 ml) of CFS from both groups, as well as sterile M17 and MRS broth, were added. The plates were left for 1 h at room temperature under a laminar flow hood. Plates were incubated at 37 C for 24 h, and antimicrobial activities were recorded as a clear inhibition zone around the wells.
The same approach was applied to check the sensitivity of 25 selected endogenous LAB strains (out of 102) representing 11 distinct species (Lactobacillus kunkeei, Lactobacillus casei, Lactobacillus spp., Lactobacillus kullabergensis, Lactobacillus helsingborgensis, Fructobacillus fructosus, Fructobacillus pseudoficulneus, Fructobacillus tropaeoli, Bifidobacterium asteroides, E. faecalis, E. durans) against bacteriocin-producing strains.
Results
Endogenous LAB strains of the bees used in this study in an in vitro system did not inhibit honeybee pathogenic strains of P. larvae or the strain L. sakei subsp. sakei JCM 1157 used as the indicator bacteria, which is sensitive to various bacteriocins.
No clear zone formation was detected around any of the lawns made in soft agar after adding raw (not neutralized) or neutralized CFS.
In our study, the bacteriocin-producing exogenous bacterial strains, E. durans A5-11, E. faecalis KT2W2G and L. lactis subsp. lactis KT2W2L, inhibited all the target strains including both P. larvae strains tested. Inhibition was detected even after neutralization of CFS with NaOH solution and after boiling for 10 min. The inhibitory effect vanished only after treatment with proteinase K solution, meaning that the antimicrobial substances present in CFS were digested by this enzyme, confirming their proteinaceous nature.
The sensitivity profiles of 25 endogenous LAB strains are presented in Table 1 . The bacteriocin-producing strains tested were absolutely inactive against the strains belonging to the Lactobacillus spp. group. Different patterns were observed for the other groups tested. These patterns of LAB sensitivity to bacteriocin-producing strains are presented in Fig. 1 .
Discussion and conclusion
The rare occurrence of bacteriocin-producing strains in intestinal bacterial dwellers might agree with the hypothesis that bacteriocins are more potent against strains closely related to the producer strain [20, 21] . If the occurrence of such a phenomenon was common in gut bacterial dwellers, their rich biodiversity would no longer exist.
The honeybee LAB was tested in an in vivo system, particularly in honeybee larvae, against P. larvae when artificial infection was accompanied by the administration of endogenous LAB. In the same study, the authors observed that the honeybee endogenous LAB inhibited Melissococcus plutonius, which causes European Foulbrood, in an in vitro system [22] . An analogous study carried out later yielded similar results towards the tested M. plutonius strain [6] . According to these works, the effectiveness of endogenous LAB against the bacterial pathogens increased markedly when a mixture of LAB was used; however, the mechanisms of antimicrobial action have never been directly attributed to bacteriocin action.
The production of bacteriocin-like inhibitory substances (BLIS) was reported for some Enterococcus strains isolated from honeybee intestines [23] . However, the Enterococcus group is not abundant in honeybee intestinal samples when compared to Lactobacilli. Additionally, E. faecalis was reported to be a coinfecting bacterium when M. plutonius infection was developing [24] .
Only one strain of L. kunkeei was reported as an efficient inhibitor of M. plutonius growth. Its inhibition was tentatively attributed to the production of an antibacterial peptide or protein [25] .
A recent study focusing on honeybee LAB exposed to microbial stressors demonstrated that LAB produced different extracellular proteins with putative antimicrobial functions; these need to be investigated further [26] .
Inhibition of P. larvae by exogenous LAB in vitro has also been demonstrated by other authors [7, 8] . It is worth pointing out that Yoshiyama et al. [7] verified that the studied LAB were immune activators too, by analyzing the transcription level patterns of antimicrobial peptide genes.
The efficacy of bacteriocins produced by exogenous LAB strains against P. larvae strains discovered in our experiments seems promising for their use in an MRM approach.
However, the following questions should be answered:
1) In which form should the bacteriocins be applied in the honeybee colonies?
Purified bacteriocins are very expensive to produce [27] . Establishing exogenous bacteriocin-producing LAB strains in the honeybee gastrointestinal tract (GIT) may be difficult, since these strains could be eliminated from areas already well colonized by the microbiota, which coevolved with bees and are very well adapted to this niche. Additionally, bacteriocin-producing strains are usually isolated from nonliving food sources [28, 29] . Exogenous strains, such as E. durans, may be devoid of such vital capacities as adhesion to the intestinal surfaces of bee GIT. To date, it is hard to find a convincing example of the use of a single bacteriocinproducing strain for the treatment or prevention of bacterial diseases in in vivo systems. Enterococci are usually used for food fermentation [30] , not only contributing to fermentation but Table 1 e Antimicrobial spectrum of bacteriocinproducing strains against honeybee endogenous LAB.
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2) If incorporated successfully into bee GIT, exogenous bacterial strains may alter the already established microbial community, as has been observed during intense antibiotic treatments.
The varied sensitivity profiles of honeybee endogenous LAB towards the tested bacteriocin-producing exogenous strains detected by the present study confirm the validity of such concerns. Moreover, the impact of probiotic bacteria on the endogenous microbial community by simple competition or antagonism has already been observed in humans and animals [32] . The evolving holistic view of holobiont complexity [33] should be seen as a warning.
3) The stability of bacteriocins in honeybee GIT should be evaluated.
Honeybee GIT and honeybee products are rich in various enzymes [34] . Hence, the presence of honey proteases and peptidases may neutralize all bacteriocins.
The antimicrobial activities of LAB are determined not only by bacteriocins but also by various other secondary metabolites, which are known to exert synergistic actions. The exact functions of insect microbiota still remain very poorly known. This question merits further exploration for a better understanding of its physiological functions.
Despite considerable efforts in formulating potent probiotic treatments adapted to protect honeybees, many issues remain unresolved. 
